Overview
This interim process statement sets out to guide the development of 'Evidence summaries: new medicines' (ESNMs). It provides an overview of the key process principles and describes all stages of the development of ESNMs.
This is not the current process. From May 2013, ESNMs were developed using the integrated process statement.
Last reviewed: 1 June 2012